Medical Marijuana, Industrial Hemp And Cannabis Information - Hemp Gazette - Page 220

LATEST ARTICLES

Australian Cannabis Policy & Law

Australian Cannabis As Medicine Survey (CAMS-16) Results Released

Terry Lassitenaz - August 16, 2018

Equities, Investment & Market Trends

Dr. Sanjay Gupta Putting His Name To Medical Cannabis

Steven Gothrinet - August 15, 2018

Access & Prescribing (Australia & Global)

Can Overseas Travelers Bring Medical Cannabis Into Australia?

Steven Gothrinet - August 14, 2018

Access & Prescribing (Australia & Global)

The Crazy-High Price Of Cannabidiol Medicine Epidiolex

Gillian Jalimnson - August 13, 2018

Cannabinoid Pharmacology

CannPal Teams Up With University Of Melbourne On Canine Epilepsy Research

Terry Lassitenaz - August 10, 2018

Access & Prescribing (Australia & Global)

Revised Medical Cannabis Emergency Rules Now Law In Oklahoma

Steven Gothrinet - August 9, 2018

Global Regulatory Updates

Stealing Industrial Hemp Can Be A Serious Offence

Gillian Jalimnson - August 8, 2018

Australian Cannabis Policy & Law

The End Of Canada’s Medical Cannabis Program?

Gillian Jalimnson - August 7, 2018

Agronomy & Cultivation Science

Australia’s First Research Hub for Medicinal Agriculture Funded

Terry Lassitenaz - August 6, 2018

Access & Prescribing (Australia & Global)

Autism And Sleep Apnea Patients Gain Medical Cannabis Access In Minnesota

Steven Gothrinet - August 3, 2018

1...219220221...291 Page 220 of 291

MOST POPULAR

Global Regulatory Updates

Green Light From USDA For New York’s Hemp Program

Gillian Jalimnson - December 31, 2021

Well, that was cutting it fine - but New York now has the feds' blessing to continue cultivating hemp in the state.The USDA’s interim...

Access & Prescribing (Australia & Global)

THC Vs. CBD: Australian Medical Cannabis Consumer Insights

Gillian Jalimnson - February 27, 2024

An Australian study of medicinal cannabis use indicates distinct demographic preferences between legally prescribed tetrahydrocannabinol (THC) and cannabidiol (CBD) products.A group of researchers primarily...

Global Regulatory Updates

“Archaic” Cannabis Scheduling Dumped By U.N.

Terry Lassitenaz - December 7, 2020

The United Nations Commission on Narcotic Drugs (CND) has voted to remove cannabis and cannabis resin from Schedule IV of the 1961 Single Convention...

Cannabinoid Pharmacology

Little Green Pharma And OBJ Partner On Transdermal Cannabinoid Therapy

Terry Lassitenaz - June 21, 2019

Australia's Little Green Pharma has teamed up with OBJ (ASX:OBJ) in a collaboration to deliver cannabinoid therapy transdermally; i.e. via the skin.The companies will...